Elbit Medical Technologies Ltd. is a holding company, which engages in the field of life sciences and medical equipment. It operates through the Insightec and Gamida Cell segments. The Insightec segment is involved research, development, production, and marketing of therapeutic medical systems based on a technological platform, which combines the use of a focused ultrasound beam and magnetic resonance imaging intended for performing non-invasive treatments on the human body. The Gamida Cell segment offers research and development of medical products based on stem cells derived mainly from umbilical cord blood for the purpose of bone marrow transplantation in patients with non-malignant blood diseases, blood or lymph node cancer, and metabolic genetic diseases. The company was founded on February 23, 1992 and is headquartered in Hod Ha'Sharon, Israel.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company